Thomas E. D'Ambra is Director at ALBANY MOLECULAR RESEARCH INC (AMRI). They have made 1 open-market trade across 1 company since 2015, most recently 2017-08-31.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AMRI | 2,455,039 | $53.4M |
Shares reported on the most recent Form 4, priced at the 2017-09-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AMRI | SELL | 2015-11-09 | 2015-11-10 | $19.60 | $980K | -12.1% | -2.5% | -22.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.